Histopathology is not typically the primary method for diagnosing C1 inhibitor deficiency. However, it can provide supportive evidence. The diagnosis is usually confirmed through blood tests that measure the levels and function of C1 inhibitor. In some cases, genetic testing is performed to identify mutations in the SERPING1 gene, which encodes the C1 inhibitor protein.
